A Prospective Intervention Study on Higher-Dose Oseltamivir Treatment in Adults Hospitalized With Influenza A and B Infections - Lee, N.; Hui, D. S. C.; Zuo, Z.; Ngai, K. L. K.; Lui, G. C. Y.; Wo, S. K.; Tam, W. W. S.; Chan, M. C. W.; Wong, B. C. K.; Wong, R. Y. K.; Choi, K. W.; Sin, W. W. Y.; et al. (Clinical infectious diseases, 2013)
Keywords: Aged; Aged, 80 and over; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antiviral agents; Antiviral Agents - administration & dosage; Antiviral Agents - blood; Antiviral Agents - pharmacokinetics; Antiviral drugs; Antivirals; ARTICLES AND COMMENTARIES; Biological and medical sciences; Chromatography; Comparators; Dosage; Drug dosages; Female; Health outcomes; Hong Kong - epidemiology; Hospitalization; Human viral diseases; Humans; Infections; Infectious diseases; Influenza; Influenza A virus - isolation & purification; Influenza B virus - isolation & purification; Influenza, Human - drug therapy; Influenza, Human - epidemiology; Influenza, Human - virology; Male; Mass spectrometry; Medical sciences; Medical treatment; Middle Aged; Nasopharynx - virology; Oseltamivir - administration & dosage; Oseltamivir - blood; Oseltamivir - pharmacokinetics; Oxygen; Pharmacology. Drug treatments; Prospective Studies; Treatment Outcome; Viral diseases; Viral diseases of the respiratory system and ent viral diseases; Viral Load; Viral RNA; Virology; Viruses; Hong Kong; Human; Neuraminidase inhibitor; Enzyme; Enzyme inhibitor; Hospitalization; Glycosylases; Infection; Oseltamivir; Treatment; Exo-α-sialidase; Glycosidases; Viral disease; Hydrolases; Adult; Antiviral; Influenza A; Dose; Influenza B; influenza; treatment; oseltamivir; viral clearance; high dose